Khong, Brian <br/><br/>
Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2.  [electronic resource] 

 -  BMC cancer  Oct 2018 
 - 1007 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/s12885-018-4810-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--administration & dosage<br/>Carcinoma, Renal Cell--drug therapy<br/>Dose-Response Relationship, Drug<br/>Female<br/>Fever--chemically induced<br/>Humans<br/>Immunotherapy--adverse effects<br/>Interleukin-2--administration & dosage<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Neoplasm Staging--methods<br/>Renal Insufficiency--chemically induced<br/>Retrospective Studies<br/>Treatment Outcome